Detalles de la búsqueda
1.
Predictors of loss to follow up among patients with type 2 diabetes mellitus attending a private not for profit urban diabetes clinic in Uganda - a descriptive retrospective study.
BMC Health Serv Res
; 19(1): 598, 2019 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31443649
2.
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
N Engl J Med
; 371(3): 234-47, 2014 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25014688
3.
Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.
Int J Equity Health
; 16(1): 154, 2017 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28836972
4.
Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective.
BMC Pulm Med
; 17(1): 179, 2017 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29216852
5.
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study.
BMJ Open Diabetes Res Care
; 10(2)2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35450869
6.
HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study.
BMJ Open Diabetes Res Care
; 9(1)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34535465
7.
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
Lancet Infect Dis
; 18(1): 47-57, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108797
8.
Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial.
J Acquir Immune Defic Syndr
; 71(5): 506-13, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26579985
9.
Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.
AIDS
; 17 Suppl 3: S39-48, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-14565608
10.
Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients.
AIDS Res Hum Retroviruses
; 18(16): 1181-7, 2002 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12487824
11.
Peripheral arterial disease among adult diabetic patients attending a large outpatient diabetic clinic at a national referral hospital in Uganda: a descriptive cross sectional study.
PLoS One
; 9(8): e105211, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25133533
12.
Suboptimal glycaemic and blood pressure control and screening for diabetic complications in adult ambulatory diabetic patients in Uganda: a retrospective study from a developing country.
J Diabetes Metab Disord
; 13(1): 40, 2014 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24593933
13.
Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified?
J Diabetes Metab Disord
; 12(1): 17, 2013 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23651730
14.
Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.
J Acquir Immune Defic Syndr
; 38(5): 578-83, 2005 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15793369
15.
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.
Lancet
; 360(9326): 34-40, 2002 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-12114039
Resultados
1 -
15
de 15
1
Próxima >
>>